Pictet & Cie Europe SA grew its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 4.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 143,368 shares of the medical research company’s stock after purchasing an additional 6,655 shares during the period. Pictet & Cie Europe SA’s holdings in Exact Sciences were […]
Compass Financial Advisors LLC lifted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 23.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 16,657 shares of the medical research company’s stock after purchasing an additional 3,131 shares during the period. […]
Goldstein Advisors LLC acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 5,410 shares of the medical research company’s stock, valued at approximately $268,000. Several other hedge […]
Should You Buy or Sell Exact Sciences Stock? Get The Latest EXAS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Resources Investment Advisors LLC. lifted its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,193 shares of the medical research company’s stock after purchasing an additional 1,023 shares […]